We are not aware of such studies in group A in PD but an example from the dementia field would be for intra-cisternal PR006 administration of the progranulin protein (PGRN) in carriers of the progranulin gene mutation (https://clinicaltrials.ucsf.edu/trial/NCT04408625). Here, GRN is linked to Parkinson disease.